about
OSU-03012 interacts with lapatinib to kill brain cancer cellsFunctional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1.Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs.Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradationDesign, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumorsCytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways.Epidermal growth factor receptor as a therapeutic target in glioblastoma.Modulatory Effects of Curcumin and Tyrphostins (AG494 and AG1478) on Growth Regulation and Viability of LN229 Human Brain Cancer Cells.Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells.Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.Bcl-2 family member Mcl-1 expression is reduced under hypoxia by the E3 ligase FBW7 contributing to BNIP3 induced cell death in glioma cellsRecent advances of bispecific antibodies in solid tumors.ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.Glioma in Schizophrenia: Is the Risk Higher or Lower?
P2860
Q34300517-09B6DC40-EC8E-4E0A-A40F-669BD835F081Q34504860-F73D49BE-2F9F-41B4-AA6D-2B907DB4B002Q35234429-FC992189-46FB-4D03-85AF-66038679DB53Q35913109-A306DFA6-4342-4776-8B24-0A625ABC6E61Q36240247-E8A545E7-7EF8-4369-80E0-AFED888C7532Q36595257-8286437D-7ECB-4C50-8CA4-BF5C392DEE06Q36907976-2965EED1-3D74-463A-B59D-4DA75BA10055Q36916729-ACD23019-471F-4629-A257-89676B6FC825Q38098098-072D4C21-B32C-4048-9510-A6D72917CAB4Q38835764-2D4AB28E-85CF-4F02-96D2-CB5C6AA25F3BQ38862374-265A1EC8-E0C3-4471-8C4F-9BFE173216E0Q38941959-CEBF376D-9757-4CB6-A949-719FC6F3512EQ39217541-ACD4FAD7-F03F-4FB5-B4E7-88CAD384CCFCQ41584301-B4D82462-08DB-4C65-91F9-1A620D72C686Q41696278-EC58C634-7E55-4116-9F33-303CD17FF4C6Q55080493-30F57AAD-7E87-4A7D-9D52-0326AB41711EQ58767549-F640667E-F727-4721-A4B4-BE60957069F7
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting ErbB receptors in high-grade glioma.
@en
Targeting ErbB receptors in high-grade glioma.
@nl
type
label
Targeting ErbB receptors in high-grade glioma.
@en
Targeting ErbB receptors in high-grade glioma.
@nl
prefLabel
Targeting ErbB receptors in high-grade glioma.
@en
Targeting ErbB receptors in high-grade glioma.
@nl
P1476
Targeting ErbB receptors in high-grade glioma.
@en
P2093
Jürgen Schlegel
P304
P356
10.2174/138161211797249233
P577
2011-01-01T00:00:00Z